Theodoros-Filippos Valamvanos

Dr. Theodoros-Filippos Valamvanos

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Chemosensors
Verified
Journal Article
Open access
PDF file
NLNefeli Lagopati
Nefeli Lagopati
TVTheodoros-Filippos Valamvanos
Theodoros-Filippos Valamvanos
VPVaia Proutsou
Vaia Proutsou
KKKonstantinos Karachalios
Konstantinos Karachalios
Natassa PippaNatassa Pippa
Natassa Pippa
Efstathios P. EfstathopoulosEfstathios P. Efstathopoulos
Efstathios P. Efstathopoulos
Early-stage, precise disease diagnosis and treatment has been a crucial topic of scientific discussion since time immemorial. When these factors are combined with experience and scientific knowledge, they can benefit not only the patient, but also, by extension, the entire health system. The development of rapidly growing novel technologies allows for accurate diagnosis and treatment of disease. Nanomedicine can contribute to exhaled breath analysis (EBA) for disease diagnosis, providing nanomaterials and improving sensing performance and detection sensitivity. Through EBA, gas-based nano-sensors might be applied for the detection of various essential diseases, since some of their metabolic products are detectable and measurable in the exhaled breath. The design and development of innovative nanomaterial-based sensor devices for the detection of specific biomarkers in breath samples has emerged as a promising research field for the non-invasive accurate diagnosis of several diseases. EBA would be an inexpensive and widely available commercial tool that could also be used as a disease self-test kit. Thus, it could guide patients to the proper specialty, bypassing those expensive tests, resulting, hence, in earlier diagnosis, treatment, and thus a better quality of life. In this review, some of the most prevalent types of sensors used in breath-sample analysis are presented in parallel with the common diseases that might be diagnosed through EBA, highlighting the impact of incorporating new technological achievements in the clinical routine.

1 March 2024 in Biomimetics
Verified
Journal Article
Open access
PDF file
TVTheodoros-Filippos Valamvanos
Theodoros-Filippos Valamvanos
XDXanthippi Dereka
Xanthippi Dereka
HKHector Katifelis
Hector Katifelis
Maria GazouliMaria Gazouli
Maria Gazouli
NLNefeli Lagopati
Nefeli Lagopati
The rehabilitation of alveolar bone defects of moderate to severe size is often challenging. Currently, the therapeutic approaches used include, among others, the guided bone regeneration technique combined with various bone grafts. Although these techniques are widely applied, several limitations and complications have been reported such as morbidity, suboptimal graft/membrane resorption rate, low structural integrity, and dimensional stability. Thus, the development of biomimetic scaffolds with tailor-made characteristics that can modulate cell and tissue interaction may be a promising tool. This article presents a critical consideration in scaffold’s design and development while also providing information on various fabrication methods of these nanosystems. Their utilization as delivery systems will also be mentioned.